 Amneet Sandhu
Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 11 | 2023 | 324 | 5.320 |
Why?
| | Catheter Ablation | 11 | 2023 | 291 | 3.630 |
Why?
| | Transcatheter Aortic Valve Replacement | 5 | 2023 | 152 | 2.190 |
Why?
| | Pacemaker, Artificial | 5 | 2023 | 107 | 1.990 |
Why?
| | Atrial Appendage | 2 | 2022 | 10 | 1.630 |
Why?
| | Aortic Valve Stenosis | 5 | 2023 | 272 | 1.630 |
Why?
| | Defibrillators, Implantable | 7 | 2021 | 286 | 1.590 |
Why?
| | Cardiac Resynchronization Therapy | 3 | 2021 | 42 | 1.440 |
Why?
| | Arrhythmias, Cardiac | 4 | 2021 | 278 | 1.440 |
Why?
| | Stroke | 3 | 2023 | 1019 | 1.440 |
Why?
| | Percutaneous Coronary Intervention | 5 | 2017 | 444 | 1.440 |
Why?
| | Tachycardia, Ventricular | 7 | 2022 | 153 | 1.230 |
Why?
| | Ventricular Premature Complexes | 4 | 2022 | 26 | 1.190 |
Why?
| | Ventricular Dysfunction, Left | 3 | 2021 | 359 | 1.150 |
Why?
| | Coronary Stenosis | 2 | 2017 | 39 | 1.040 |
Why?
| | Hospitals | 4 | 2019 | 580 | 1.010 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 28 | 0.900 |
Why?
| | Pericardial Effusion | 1 | 2022 | 21 | 0.840 |
Why?
| | Heart Atria | 2 | 2023 | 108 | 0.820 |
Why?
| | Aortic Valve | 5 | 2023 | 400 | 0.810 |
Why?
| | Electrophysiologic Techniques, Cardiac | 2 | 2019 | 70 | 0.750 |
Why?
| | Esophagus | 2 | 2023 | 226 | 0.740 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.720 |
Why?
| | Therapeutic Irrigation | 2 | 2019 | 67 | 0.710 |
Why?
| | Cardiac Catheterization | 2 | 2022 | 534 | 0.680 |
Why?
| | Coronary Artery Disease | 3 | 2014 | 607 | 0.680 |
Why?
| | Shock | 1 | 2020 | 75 | 0.680 |
Why?
| | Postoperative Complications | 5 | 2019 | 2127 | 0.670 |
Why?
| | Esophageal Fistula | 1 | 2019 | 17 | 0.650 |
Why?
| | Anticoagulants | 4 | 2023 | 547 | 0.640 |
Why?
| | Heart Block | 1 | 2018 | 38 | 0.600 |
Why?
| | Electrocardiography | 6 | 2023 | 562 | 0.580 |
Why?
| | Risk Factors | 13 | 2023 | 8627 | 0.580 |
Why?
| | Treatment Outcome | 12 | 2023 | 9089 | 0.570 |
Why?
| | Cryosurgery | 1 | 2018 | 52 | 0.570 |
Why?
| | Practice Patterns, Physicians' | 2 | 2017 | 1178 | 0.560 |
Why?
| | Humans | 46 | 2023 | 114757 | 0.560 |
Why?
| | Tetralogy of Fallot | 1 | 2018 | 81 | 0.560 |
Why?
| | Tilidine | 1 | 2016 | 2 | 0.540 |
Why?
| | Pulmonary Valve | 1 | 2018 | 89 | 0.530 |
Why?
| | Heart Valve Prosthesis | 1 | 2018 | 121 | 0.530 |
Why?
| | Coronary Artery Bypass | 1 | 2017 | 198 | 0.530 |
Why?
| | Antihypertensive Agents | 2 | 2019 | 429 | 0.510 |
Why?
| | Oxycodone | 1 | 2016 | 44 | 0.510 |
Why?
| | Preoperative Care | 1 | 2018 | 317 | 0.510 |
Why?
| | Assisted Circulation | 1 | 2015 | 25 | 0.500 |
Why?
| | Naloxone | 1 | 2016 | 97 | 0.500 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 228 | 0.480 |
Why?
| | Plaque, Atherosclerotic | 1 | 2014 | 44 | 0.460 |
Why?
| | United States Department of Veterans Affairs | 1 | 2017 | 556 | 0.450 |
Why?
| | Male | 27 | 2023 | 55579 | 0.440 |
Why?
| | Blue Cross Blue Shield Insurance Plans | 1 | 2013 | 1 | 0.440 |
Why?
| | Cardiac Surgical Procedures | 1 | 2018 | 413 | 0.430 |
Why?
| | Prescriptions | 2 | 2023 | 60 | 0.430 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 102 | 0.420 |
Why?
| | Aged | 20 | 2022 | 19094 | 0.420 |
Why?
| | Thiophenes | 1 | 2013 | 108 | 0.410 |
Why?
| | Healthcare Disparities | 1 | 2017 | 479 | 0.400 |
Why?
| | Heart Failure | 4 | 2021 | 1952 | 0.390 |
Why?
| | Tachycardia, Supraventricular | 2 | 2022 | 42 | 0.390 |
Why?
| | Hypertension | 2 | 2019 | 1059 | 0.380 |
Why?
| | Administration, Oral | 2 | 2023 | 731 | 0.370 |
Why?
| | Middle Aged | 18 | 2022 | 26757 | 0.370 |
Why?
| | Retrospective Studies | 15 | 2023 | 12515 | 0.370 |
Why?
| | Piperazines | 1 | 2013 | 311 | 0.360 |
Why?
| | Registries | 7 | 2022 | 1759 | 0.360 |
Why?
| | Atrioventricular Block | 2 | 2021 | 37 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2269 | 0.340 |
Why?
| | Acute Coronary Syndrome | 1 | 2013 | 254 | 0.340 |
Why?
| | Female | 24 | 2023 | 59507 | 0.340 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2013 | 400 | 0.330 |
Why?
| | Cost-Benefit Analysis | 2 | 2022 | 545 | 0.300 |
Why?
| | Bundle-Branch Block | 3 | 2023 | 29 | 0.290 |
Why?
| | Time Factors | 8 | 2019 | 6124 | 0.280 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2023 | 79 | 0.270 |
Why?
| | Heart Defects, Congenital | 2 | 2022 | 665 | 0.260 |
Why?
| | United States | 7 | 2023 | 12176 | 0.250 |
Why?
| | Cardiomyopathies | 2 | 2019 | 298 | 0.250 |
Why?
| | Electric Countershock | 3 | 2023 | 104 | 0.250 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 1727 | 0.240 |
Why?
| | Off-Label Use | 1 | 2023 | 51 | 0.220 |
Why?
| | Death, Sudden, Cardiac | 2 | 2021 | 160 | 0.210 |
Why?
| | Heart Conduction System | 1 | 2023 | 82 | 0.210 |
Why?
| | Guideline Adherence | 2 | 2019 | 490 | 0.200 |
Why?
| | Transposition of Great Vessels | 1 | 2022 | 29 | 0.200 |
Why?
| | Prospective Studies | 5 | 2019 | 6217 | 0.200 |
Why?
| | Aged, 80 and over | 4 | 2019 | 6350 | 0.200 |
Why?
| | Sweden | 1 | 2022 | 65 | 0.200 |
Why?
| | Rivaroxaban | 1 | 2023 | 211 | 0.200 |
Why?
| | Pulmonary Veins | 1 | 2022 | 81 | 0.190 |
Why?
| | Atrial Flutter | 1 | 2021 | 25 | 0.190 |
Why?
| | Risk Assessment | 4 | 2019 | 2973 | 0.190 |
Why?
| | Accessory Atrioventricular Bundle | 1 | 2020 | 11 | 0.180 |
Why?
| | Ventricular Fibrillation | 1 | 2020 | 51 | 0.180 |
Why?
| | Bradycardia | 1 | 2021 | 48 | 0.180 |
Why?
| | Swine | 1 | 2023 | 700 | 0.180 |
Why?
| | Temperature | 1 | 2023 | 575 | 0.170 |
Why?
| | Death | 1 | 2020 | 107 | 0.170 |
Why?
| | Inpatients | 1 | 2023 | 378 | 0.170 |
Why?
| | Cardiac Catheters | 1 | 2019 | 15 | 0.170 |
Why?
| | Papillary Muscles | 1 | 2019 | 14 | 0.170 |
Why?
| | Coffee | 1 | 2019 | 10 | 0.170 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 19 | 0.170 |
Why?
| | Electrodes | 1 | 2019 | 100 | 0.170 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 467 | 0.170 |
Why?
| | Technology | 1 | 2020 | 79 | 0.170 |
Why?
| | Action Potentials | 2 | 2019 | 406 | 0.170 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 45 | 0.160 |
Why?
| | Diffusion of Innovation | 1 | 2019 | 94 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2019 | 1393 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 63 | 0.160 |
Why?
| | Adult | 7 | 2023 | 30548 | 0.160 |
Why?
| | Heart Rate | 2 | 2019 | 704 | 0.160 |
Why?
| | Heparin | 1 | 2020 | 222 | 0.160 |
Why?
| | Myocardial Infarction | 2 | 2016 | 927 | 0.160 |
Why?
| | Heart Valve Diseases | 1 | 2020 | 161 | 0.150 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 139 | 0.150 |
Why?
| | Decision Support Techniques | 1 | 2021 | 351 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4420 | 0.150 |
Why?
| | Coronary Angiography | 2 | 2017 | 304 | 0.150 |
Why?
| | Equipment Design | 1 | 2019 | 508 | 0.150 |
Why?
| | Echocardiography, Stress | 1 | 2017 | 20 | 0.150 |
Why?
| | Sarcoidosis | 1 | 2019 | 135 | 0.140 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 251 | 0.140 |
Why?
| | Hot Temperature | 1 | 2019 | 304 | 0.140 |
Why?
| | Anti-Arrhythmia Agents | 3 | 2023 | 106 | 0.140 |
Why?
| | Pharmacovigilance | 1 | 2016 | 14 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1340 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1796 | 0.130 |
Why?
| | Intra-Aortic Balloon Pumping | 1 | 2015 | 16 | 0.130 |
Why?
| | Disease Management | 1 | 2019 | 560 | 0.130 |
Why?
| | World Health Organization | 1 | 2016 | 103 | 0.130 |
Why?
| | Vasodilator Agents | 1 | 2017 | 303 | 0.130 |
Why?
| | Shock, Cardiogenic | 1 | 2015 | 53 | 0.120 |
Why?
| | Drug Combinations | 1 | 2016 | 286 | 0.120 |
Why?
| | Arterial Occlusive Diseases | 1 | 2014 | 73 | 0.120 |
Why?
| | Chagas Cardiomyopathy | 1 | 2014 | 22 | 0.110 |
Why?
| | Heart Ventricles | 1 | 2018 | 709 | 0.110 |
Why?
| | Prasugrel Hydrochloride | 1 | 2013 | 19 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1530 | 0.110 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2013 | 23 | 0.110 |
Why?
| | Contraindications | 1 | 2013 | 85 | 0.110 |
Why?
| | Program Evaluation | 1 | 2017 | 822 | 0.110 |
Why?
| | Michigan | 1 | 2013 | 96 | 0.110 |
Why?
| | Drug Utilization Review | 1 | 2013 | 57 | 0.110 |
Why?
| | Diabetic Angiopathies | 1 | 2015 | 244 | 0.110 |
Why?
| | Drug Utilization | 1 | 2013 | 167 | 0.100 |
Why?
| | Recurrence | 1 | 2015 | 936 | 0.100 |
Why?
| | Hemorrhage | 1 | 2016 | 618 | 0.100 |
Why?
| | Societies, Medical | 1 | 2015 | 663 | 0.100 |
Why?
| | Seizures | 1 | 2014 | 339 | 0.090 |
Why?
| | Catheters | 2 | 2022 | 63 | 0.090 |
Why?
| | Comorbidity | 1 | 2015 | 1449 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2013 | 287 | 0.090 |
Why?
| | Incidence | 3 | 2021 | 2312 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 537 | 0.090 |
Why?
| | Patient Discharge | 1 | 2016 | 769 | 0.090 |
Why?
| | Hospital Mortality | 1 | 2013 | 776 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2015 | 2386 | 0.080 |
Why?
| | Stroke Volume | 2 | 2020 | 508 | 0.070 |
Why?
| | Young Adult | 2 | 2020 | 10463 | 0.070 |
Why?
| | Quality Improvement | 1 | 2013 | 951 | 0.060 |
Why?
| | Bundle of His | 1 | 2023 | 16 | 0.060 |
Why?
| | Cardiac Electrophysiology | 1 | 2021 | 12 | 0.050 |
Why?
| | Atrioventricular Node | 1 | 2021 | 14 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2023 | 145 | 0.050 |
Why?
| | Animals | 1 | 2023 | 31762 | 0.050 |
Why?
| | Tachycardia | 1 | 2021 | 50 | 0.050 |
Why?
| | Colorado | 2 | 2021 | 4086 | 0.050 |
Why?
| | Patient Readmission | 2 | 2016 | 608 | 0.040 |
Why?
| | Antithrombins | 1 | 2020 | 49 | 0.040 |
Why?
| | Tricuspid Valve | 1 | 2019 | 25 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 3334 | 0.040 |
Why?
| | Hospitalization | 2 | 2021 | 1752 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2021 | 582 | 0.040 |
Why?
| | Systole | 1 | 2019 | 171 | 0.040 |
Why?
| | Mitral Valve | 1 | 2019 | 87 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 234 | 0.040 |
Why?
| | Pilot Projects | 1 | 2021 | 1370 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 554 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 954 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 514 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 931 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 665 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1642 | 0.030 |
Why?
| | Child | 2 | 2022 | 18352 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 2249 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2016 | 1080 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2387 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2763 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 4625 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4409 | 0.020 |
Why?
| | Cohort Studies | 1 | 2014 | 4901 | 0.020 |
Why?
| | Adolescent | 1 | 2022 | 17808 | 0.010 |
Why?
|
|
Sandhu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|